Initial Drug Management for Wolff-Parkinson-White (WPW) Syndrome
Critical First Step: Identify the QRS Complex Width
- The American College of Cardiology recommends that a narrow QRS complex (<120 ms) during tachycardia indicates anterograde conduction through the AV node (orthodromic AVRT), which is the most common arrhythmia in WPW syndrome 1, 3
- A wide QRS complex (≥120 ms) during tachycardia indicates anterograde conduction through the accessory pathway (pre-excited AF or antidromic AVRT), which carries risk of degeneration to ventricular fibrillation 1, 3
Treatment Algorithm Based on Arrhythmia Type
For Narrow-Complex Tachycardia (Orthodromic AVRT)
- The American Heart Association recommends vagal maneuvers (Valsalva or carotid sinus massage) as first-line treatment, which terminate up to 25% of cases 4
- Adenosine 6 mg IV push is recommended as second-line treatment, which terminates approximately 95% of orthodromic AVRT by blocking AV nodal conduction 4, 3
For Wide-Complex Tachycardia (Pre-Excited Atrial Fibrillation)
- The American College of Cardiology recommends immediate direct-current cardioversion for hemodynamically unstable patients 1, 2
- For hemodynamically stable patients, IV procainamide or ibutilide is recommended to restore sinus rhythm or slow ventricular rate 1, 2
Absolutely Contraindicated Medications in Pre-Excited AF
- The American College of Cardiology advises against administering adenosine, digoxin, nondihydropyridine calcium channel blockers, beta-blockers, and IV amiodarone in patients with WPW who have wide-complex tachycardia or pre-excited atrial fibrillation, as they can precipitate ventricular fibrillation 1, 2
Important Clinical Caveats
- Risk stratification is crucial, as patients with short RR intervals (<250 ms) between pre-excited beats during atrial fibrillation, history of symptomatic tachycardia, or multiple accessory pathways are at highest risk for sudden cardiac death (2.2% annual risk in symptomatic patients vs 0.15-0.2% in general WPW population) 2